These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9796204)

  • 21. Uncovering and characterizing multiple sclerosis lesions: the aid of fluid-attenuated inversion recovery images in the presence of gadolinium contrast agent.
    Bagnato F
    J Neuroimaging; 2009 Jul; 19(3):201-4. PubMed ID: 19187471
    [No Abstract]   [Full Text] [Related]  

  • 22. Interferon-alpha 2a treatment of neuro-Behcet disease.
    Nichols JC; Ince A; Akduman L; Mann ES
    J Neuroophthalmol; 2001 Jun; 21(2):109-11. PubMed ID: 11450899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance contrast enhancement with gadolinium-DTPA in patients with angina and angiographically normal coronary arteries: effect of chronic beta-blockade.
    Rossetti E; Fragasso G; Mellone R; Vanzulli A; Del Maschio A; Chierchia SL
    Cardiologia; 1999 Jul; 44(7):653-9. PubMed ID: 10476591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Neuro-Behçet disease with solitary cerebral pseudotumor disclosed by headaches].
    Dupin M; Zimmermann R; Flocard F; Guennoc B; Antoniotti O; Flechaire A; Combemale P
    Ann Med Interne (Paris); 1996; 147(7):524-6. PubMed ID: 9092369
    [No Abstract]   [Full Text] [Related]  

  • 25. MRI features of Neuro-Behçet disease.
    Deprez FC; Wertz M; Cosnard G
    JBR-BTR; 2008; 91(5):221. PubMed ID: 19051948
    [No Abstract]   [Full Text] [Related]  

  • 26. [Contrast-enhanced MR imaging using double doses of gadolinium-DTPA in evaluating brain and spinal diseases].
    Matsumoto S; Hasuo K; Uchino A; Matsuura Y; Gibo M; Fukui M; Masuda K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 May; 53(5):503-10. PubMed ID: 8327315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristic neuroimaging in patients with tumefactive demyelinating lesions exceeding 30 mm.
    Kiriyama T; Kataoka H; Taoka T; Tonomura Y; Terashima M; Morikawa M; Tanizawa E; Kawahara M; Furiya Y; Sugie K; Kichikawa K; Ueno S
    J Neuroimaging; 2011 Apr; 21(2):e69-77. PubMed ID: 20572907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neuro-Behcet disease mimicking a thalamic tumor].
    Yoshimura J; Toyama M; Sekihara Y; Tamatani S; Nagai H; Fujita S; Emura I; Yamada M
    No Shinkei Geka; 2001 Jun; 29(6):527-31. PubMed ID: 11452498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of ectopic pancreas in dynamic gadolinium-enhanced MRI.
    Okuhata Y; Maebayashi T; Furuhashi S; Abe K; Takahashi M; Kanamori N; Inoue K; Takayama T
    Abdom Imaging; 2010 Feb; 35(1):85-7. PubMed ID: 19048331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization.
    Kubaska S; Sahani DV; Saini S; Hahn PF; Halpern E
    Clin Radiol; 2001 May; 56(5):410-5. PubMed ID: 11384141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents.
    Husarik DB; Gupta RT; Ringe KI; Boll DT; Merkle EM
    Acad Radiol; 2011 Dec; 18(12):1549-54. PubMed ID: 21958599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paramagnetic enhancement of cerebral lesions with gadolinium-DTPA.
    Hesselink JR; Dunn WM; Healy ME; Hajek P; Baker L; Brahme FJ
    Acta Radiol Suppl; 1986; 369():558-60. PubMed ID: 2980556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuro-Behçet disease. A review.
    Borhani Haghighi A; Pourmand R; Nikseresht AR
    Neurologist; 2005 Mar; 11(2):80-9. PubMed ID: 15733330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efficacy of gadobenate dimeglumine vs gadopentetate dimeglumine in contrast- enhanced magnetic resonance imaging for diagnosis of solitary brain metastases].
    Wang QJ; Wang Y; Xu X; Xiao H; Ma L
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):1968-73. PubMed ID: 22200693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple focal nodular hyperplasia syndrome: diagnosis with dynamic, gadolinium-enhanced MRI.
    Finley AC; Hosey JR; Noone TC; Shackelford DM; Varadarajulu S
    Magn Reson Imaging; 2005 Apr; 23(3):511-3. PubMed ID: 15862653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Brain MRI of reversible, recurrent white matter lesions in a patient with a 35-year history of neuro-Behçet disease].
    Fukuda K; Ishida S; Sakane S; Furukawa K; Sugino M
    Brain Nerve; 2009 Jun; 61(6):701-5. PubMed ID: 19526839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnetic resonance spectroscopic findings in neuro-Behçet disease.
    Scully SE; Stebner FC; Yoest SM
    Neurologist; 2004 Nov; 10(6):323-6. PubMed ID: 15518598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. More on pseudohypocalcemia and gadolinium-enhanced MRI.
    Prince MR; Choyke PL; Knopp MV
    N Engl J Med; 2004 Jan; 350(1):87-8; author reply 87-8. PubMed ID: 14702437
    [No Abstract]   [Full Text] [Related]  

  • 39. Reversibility of CT and MR findings in neuro-Behçet disease.
    Patel DV; Neuman MJ; Hier DB
    J Comput Assist Tomogr; 1989; 13(4):669-73. PubMed ID: 2745786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pseudo-tumor form of neuro-Behçet disease: case study and literature review].
    Guini M; Khoulali M; Raouzi N; Ouali N; Moufid F
    Pan Afr Med J; 2019; 33():194. PubMed ID: 31692738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.